Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation

Transplantation

Volumn 87, Issue 2, 2009, Pages 261-267

  Yoshitoshi, Elena Y ^a   Takada, Yasutsugu ^a   Oike, Fumitaka ^a   Sakamoto, Seisuke ^a   Ogawa, Kohei ^a   Kanazawa, Hiroyuki ^a   Ogura, Yasuhiro ^a   Okamoto, Shinya ^a   Haga, Hironori ^a   Ueda, Mikiko ^a   Egawa, Hiroto ^a   Kasahara, Mureo ^b   Tanaka, Koichi ^c   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Copper metabolism; Heterozygous donor; Metabolic disease; Neuropsychologic presentation; Survival

Indexed keywords

CERULOPLASMIN; COPPER; WILSON DISEASE PROTEIN; ADENOSINE TRIPHOSPHATASE; CATION TRANSPORT PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; FEMALE; FOLLOW UP; GENE MUTATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; JAPAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINALYSIS; WILSON DISEASE; BLOOD; GENETICS; HETEROZYGOTE; HOSPITALIZATION; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; MUTATION; NEUROPSYCHOLOGICAL TEST; REOPERATION; RETROSPECTIVE STUDY; TIME; URINE;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; CATION TRANSPORT PROTEINS; CERULOPLASMIN; CHILD; COPPER; FEMALE; GRAFT SURVIVAL; HEPATOLENTICULAR DEGENERATION; HETEROZYGOTE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MUTATION; NEUROPSYCHOLOGICAL TESTS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59649117143     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181919984     Document Type: Article

References (30)

1. Yarze JC, Martin P, Munoz SJ, et al. Wilson's disease: Current status. Am J Med 1992; 92: 643.
2. Walshe JM. Penicillamine, a new oral therapy for Wilson's disease. Am J med 1956; 21: 487.
3. Stremmel W, Meyerrose KW, Niederau C, et al. Wilson's disease: Clinical presentation, treatment, and survival. Ann Intern Med 1991; 115: 720.
4. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: Indications and outcome. Hepatology 1994; 19: 583.
5. Ala A, Walker AP, Keyoumars A, et al. Wilson's disease. Lancet 2007; 369: 397.
6. Dhawan A, Taylor RM, Cheeseman P, et al. Wilson's disease in children: 37-Year experience and revised King's score for liver transplantation. Liver Transpl 2005; 11: 441.
7. Stracciari A, Tempestini A, Borghi A, et al. Effect of liver transplantation on neurological manifestation in Wilson's disease. Arch Neurol 2000; 57: 384.
8. Eghtesad B, Nezakatgoo N, Geraci LC, et al. Liver transplantation for Wilson's disease:A single-center experience. Liver Transpl Surg1999; 5: 467.
9. Rothfus WE, Hirsch WL, Jeffrey M, et al. Improvement of cerebral CT abnormalities following liver transplantationinapatient with Wilson's disease. J Comput Assist Tomogr 1988; 12: 138.
10. Pellecchia MT, Criscuolo C, Longo K, et al. Clinical presentation and treatment of Wilson's disease: A single-centre experience. Eur Neurol 2003; 50: 48.
11. Wang X, Cheng F, Zhang F, et al. Living-related liver transplantation for Wilson's disease. Transpl Int 2005; 18: 651.
12. Geissler I, Heinemann K, Rohm S, et al. Liver transplantation for hepatic and neurological Wilson's disease. Transpl Proc 2003; 35: 1445.
13. Medici V, Mirante VG, Fassati LR, et al. Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders. Liver Transpl 2005; 11: 1056.
14. Schumacher G, Platz KP, Mueller AR, et al. Liver transplantation: Treatment ofchoice for hepatic and neurological manifestation of Wilson's disease. Clin Transpl 1997; 11: 217.
15. Kobayashi S, Ochiai T, Hori S, et al. Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor. Hepatogastroenterology 2001; 48: 1259.
16. Komatsu H, Fujisawa T, Inui A, et al. Hepatic copper concentration in children undergoing living related liver transplantation due to Wilsonian fulminant hepatic failure. Clin Transpl 2002; 16: 227.
17. Tanaka K, Inomata Y. Present status and prospective of living-related liver transplantation. J Hepat Bil Pancr Surg 1997; 4: 51.
18. Tamura S, Sugawara Y, Akamatsu N, et al. Living-related liver transplantation for Wilson's disease. Clin Transpl 2005; 19: 483.
19. Morioka D, Kasahara M, Takada Y, et al. Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant 2005; 5: 2754.
20. Asonuma K, Inomata Y, Kasahara M, et al. Living related liver transplantation from heterozygote genetic carriers tochildren with Wilson's disease. Pediatr Transpl 1999; 3: 201.
21. Rand EB. This liver is a giver: Wilson' disease and living related liver transplantation. Pediatr Transpl 1999; 3: 169.
22. Roberts EA, Schilsky ML.Apractice guidelineon Wilson disease. Hepatology 2003; 37: 1475.
23. Takaku F, Kurokawa K, Kasuga M, et al. Lab data test selection and interpretation. Igaku-Sho-In 2003-2004; 151: 193.
24. Tanaka K, Uemoto S, Tokunaga Y, Surgical techniques and innovations in living-related liver transplantation. Ann Surg 1993; 217: 82.
25. Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosuppression with FK 506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247.
26. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004; 77: 403.
27. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513.
28. Kasahara M, Takada Y, Egawa H, et al. Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transpl 2005; 5: 558.
29. OkadaT, Shiono Y,Hayashi H, et al. Mutational analysis ofATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat 2000; 15: 454.
30. Santos RG, Alissa F, Reyes J, et al. Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation. Pediatr Transpl 2005; 9: 112.